Freenome, Inc. Common stock (FRNM)

Freenome, Inc. Common stock (FRNM) is a Diagnostics & Research company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $1.4B; returns 1 day -2.5%, 1 week +8.7%.

Freenome, Inc. is a precision diagnostics company that went public on July 21, 2026, via a merger with Perceptive Capital Solutions Corp. The company operates a multiomics platform that combines genomic, epigenomic, and proteomic biomarkers with proprietary machine learning and AI algorithms to detect cancer at early, treatable stages through routine blood draws.

Groups FRNM belongs to

• Recent IPOs
• Precision Medicine
• Early Cancer Detection
• Biotechnology
• Healthcare Technology
• Artificial Intelligence
• Health Diagnostics and Imaging
• Healthcare
• Machine Learning
• Oncology
• AI in Healthcare

FRNM financial model: income statement, cash flow and balance sheet